Key result
Expert consensus emphasizes clearer definitions and biotechnological advances to improve timely lupus diagnosis.
Answers are grounded in this paper and cite their sources.
Lupus is a complex disease that is often difficult to diagnose. Risks of diagnostic delays include non-specific signs and symptoms that mimic other diseases and a lack of diagnostic criteria and referral pathways for non-specialists. To address these issues, we convened a series of virtual meetings with members of our Addressing Lupus Pillars for Health Advancement clinical care team. Meeting participants included lupus physicians, treatment developers from biotechnology, patient advocacy group representatives from the Lupus Foundation of America and advocacy/government consultants. Causes and consequences of ambiguity in diagnosis and diagnostic delays were evaluated through historical, experiential and evidence-based accounts (survey data, literature reviews and patient testimonials). Discussions highlighted the need for a clearer understanding of the definition of lupus, the natural history of the disease and the need for advancements in biotechnology to support an accurate and timely diagnosis with the potential development of a lupus spectrum.
No takes yet. Share an insight, caveat, or question.
Bruce et al. (2023) studied Lupus. Lupus diagnostic ambiguity was evaluated. Discussions among clinical and advocacy experts highlighted the need for clearer disease definitions and biotechnological advancements to support accurate and timely lupus diagnosis.
Synapse has enriched 10 related papers. Consider them for comparative context: